Large series of 114 cases with long-term follow-up of upper urinary tract urothelial tumors

被引:4
|
作者
Izquierdo, L. [1 ]
Truan, D. [2 ]
Alvarez-Vijande, R. [1 ]
Alcaraz, A. [1 ]
机构
[1] Univ Barcelona, Serv Urol, Hosp Clin, Barcelona, Spain
[2] Hosp Marques de Valdecilla, Santander, Spain
来源
ACTAS UROLOGICAS ESPANOLAS | 2010年 / 34卷 / 03期
关键词
Prognostic factor; Survival; Tumor progression; Upper urinary tract tumors; Urothelial cancer; TRANSITIONAL-CELL-CARCINOMA; PROGNOSTIC-FACTORS; RECURRENCE; SURVIVAL; CHEMOTHERAPY; VARIABLES;
D O I
10.1016/S2173-5786(10)70054-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Upper urinary tract urothelial carcinoma (UUTUC) represents 5% of all urothelial tumors and has uncertain prognostic. Exist few series which describes clinical-pathological parameters of tumor progression. The aim of this study is to evaluate clinical and pathological parameters and determine their value as prognostic factors of tumor progression and cancer-specific survival. Material and methods: Retrospective analysis of 114 cases of radical nephroureterectomy or partial ureterectomy collected between 1991-2004. Variables analyzed were age, sex, pathological tumor stage, histological tumor grade, CIS, tumor localization, multiplicity, bladder cancer history, pathological nodes and adjuvant chemotherapy. Spearman test was used for correlations. The probabilities of progression free survival and cancer-specific survival were calculated using Kaplan-Meier curves. In the multivariate analysis forward stepwise Cox regression was performed. Results: Pathological stage was: 15 pTa, 25 pT1, 26 pT2, 32 pT3 and 16 pT4. There were 10 G1 (9%), 52 G2 (45.5%) and 52 G3 (45.5%). Fifteen patients presented pathological nodes at the moment of diagnosis. Fourteen percent of 114 patients received adjuvant treatment (Platin-based regimen). Mean follow-up: 74.8 months; 30.7% of the patients developed tumor progression. Death from the disease: 24.6%. Five-years overall and cancer-specific survival: 59.3% and 72.9%, respectively. Five-year progression-free survival: 68%. Mean time of tumor progression: 12.2 months and 23.3 months for cancer-specific death. In the multivariate analysis the independent predictive variables of death and tumor progression were histological grade and pathological stage. Conclusions: We demonstrated that histological grade and pathological stage constitute independent prognostic factors of tumor progression and cancer-specific survival in UUTUC. (C) 2009 AEU. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:232 / 237
页数:6
相关论文
共 50 条
  • [41] Pineoblastomas: A long-term follow up study of three cases in Helsinki Neurosurgery
    Choque-Velasquez, Joham
    Resendiz-Nieves, Julio C.
    Jahromi, Behnam Rezai
    Colasanti, Roberto
    Tynninen, Olli
    Collan, Juhani
    Niemela, Mika
    Hernesniemi, Juha
    INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2019, 18
  • [42] Retroperitoneal nephroureterectomy with excision of cuff of the bladder for upper urinary tract transitional cell carcinoma: comparison of laparoscopic and open surgery with long-term follow-up
    Hemal, Ashok K.
    Kumar, Anup
    Gupta, Narmada P.
    Seth, Amlesh
    WORLD JOURNAL OF UROLOGY, 2008, 26 (04) : 381 - 386
  • [43] Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature
    Montano, Nicola
    D'Alessandris, Quintino Giorgio
    D'Ercole, Manuela
    Lauretti, Liverana
    Pallini, Roberto
    Di Bonaventura, Rina
    La Rocca, Giuseppe
    Bianchi, Federico
    Fernandez, Eduardo
    JOURNAL OF NEUROSURGERY, 2016, 125 (02) : 363 - 371
  • [44] Retroperitoneal nephroureterectomy with excision of cuff of the bladder for upper urinary tract transitional cell carcinoma: comparison of laparoscopic and open surgery with long-term follow-up
    Ashok K. Hemal
    Anup Kumar
    Narmada P. Gupta
    Amlesh Seth
    World Journal of Urology, 2008, 26 : 381 - 386
  • [45] Percutaneous cryoablation of hepatic tumors: long-term experience of a large US series
    Littrup, Peter J.
    Aoun, Hussein D.
    Adam, Barbara
    Krycia, Mark
    Prus, Matt
    Shields, Anthony
    ABDOMINAL RADIOLOGY, 2016, 41 (04) : 767 - 780
  • [46] Long Term Follow-Up Observation in Small Choroidal Melanocytic Tumors
    Prieto-Dominguez, Laura
    Garcia-alvarez, Ciro
    Munoz-Moreno, Maria F.
    Diezhandino, Patricia
    Miguel-Perez, David
    Saornil, Maria A.
    CANCERS, 2024, 16 (15)
  • [47] Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer
    Ou, Chien-Hui
    Yang, Wen-Horng
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (04) : 623 - 627
  • [48] A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors
    Sun, Hsu-Dong
    Lin, Hao
    Jao, Mei-Shan
    Wang, Kung-Liahng
    Liou, Wen-Shiung
    Hung, Yao-Ching
    Chiang, Ying-Cheng
    Lu, Chien-Hsing
    Lai, Hung Cheng
    Yu, Mu-Hsien
    GYNECOLOGIC ONCOLOGY, 2012, 124 (02) : 244 - 249
  • [49] A Population-based Series of Ovarian Carcinosarcomas with Long-term Follow-up
    Paulsson, Gunnar
    Andersson, Solveig
    Sorbe, Bengt
    ANTICANCER RESEARCH, 2013, 33 (03) : 1003 - 1008
  • [50] S-phase fraction in superficial urothelial carcinoma of the bladder - A prospective, long-term, follow-up study
    Falkman, K
    Tribukait, B
    Nyman, CR
    Larsson, P
    Norming, U
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2004, 38 (04): : 278 - 284